60 results
8-K
EX-99.1
OMER
Omeros Corporation
30 Dec 21
Omeros Completes Sale of OMIDRIA® Franchise to Rayner Surgical
4:30pm
and breakthrough iritis), use of pupil-expansion devices, and surgical times, (3) significantly reduce intraoperative use of the opioid fentanyl
8-K
EX-99.1
OMER
Omeros Corporation
2 Dec 21
Omeros Announces Agreement to Sell OMIDRIA® Franchise to Rayner Surgical in a Transaction Valued in Excess of $1 Billion
7:53am
) significantly reduce intraoperative use of the opioid fentanyl and postoperative prescription opioids, (4) enable performance of surgery and postoperative
8-K
EX-99.1
forzd70
9 Nov 21
Omeros Corporation Reports Third Quarter 2021 Financial Results
4:05pm
8-K
EX-99.1
3rtc 16omdi0hqrnx
9 Aug 21
Omeros Corporation Reports Second Quarter 2021 Financial Results
4:05pm
8-K
EX-99.1
pqycxv4
10 May 21
Omeros Corporation Reports First Quarter 2021 Financial Results
4:06pm
424B5
q7uj2dg8lm
1 Mar 21
Prospectus supplement for primary offering
5:16pm
8-K
EX-99.1
oi5f3lu
1 Mar 21
Omeros Corporation Reports Fourth Quarter and Year-End 2020 Financial Results
4:10pm
8-K
EX-99.1
mb925 ozu6kcx
9 Nov 20
Omeros Corporation Reports Third Quarter 2020 Financial Results
4:07pm
424B5
2squmef4l3s6df
13 Aug 20
Prospectus supplement for primary offering
6:07am
424B5
c65wn0t8
13 Aug 20
Prospectus supplement for primary offering
6:01am
424B5
br2n5gqh
10 Aug 20
Prospectus supplement for primary offering
4:46pm